AstraZeneca bresst cancer drug gets FDA approval
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) was approved in the US for the treatment of adult patients with a type of breast cancer. Enhertu is a HER2-directe…
More from Delaware Business
Delaware Business Now
Delaware charters pulled for LLC's tied to drug traffickers
Delaware Business
•
Dec 5, 2022
Delmarva Now Business
Rack Room Shoes opens in Salisbury, and a new pool hall on the way | What's Going There
Delaware Business
•
Dec 5, 2022
Delaware Business Now
Suspect dead after carjackings, pursuit by officers in I-95 area
Delaware Business
•
Dec 3, 2022
Delaware Business Now
PBF Energy acquires remaining interests in logistics business
Delaware Business
•
Dec 3, 2022
Delaware Business Now
My take: Feds take closer look at criminal monopoly actions
Delaware Business
•
Dec 3, 2022
Delaware Business Now
ChristianaCare center named in honor of donor and breast cancer survivor Tatiana Copeland
Delaware Business
•
Dec 2, 2022
Delaware State Chamber of Commerce
Veteran Business Leader and Communications Specialist to Assume Role of Vice Chair
Delaware Business
•
Dec 2, 2022